These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4239858)

  • 1. [Treatment of nonspecific intestinal complaints with the new combined preparation Mexase].
    Nicolay K
    Med Welt; 1967 Jul; 26():1579-85. PubMed ID: 4239858
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic results in non-specific intestinal disorders using Mexase].
    Zawodsky L
    Wien Med Wochenschr; 1969 Feb; 119(5):94-8. PubMed ID: 4239538
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trial of mexase in true digestive insufficiency (uncompensated malabsorption) or functional (malabsorption compensated)].
    Delmont J
    Mars Med; 1972; 109(1):87-90. PubMed ID: 4259725
    [No Abstract]   [Full Text] [Related]  

  • 4. [Enzyme therapy with Mexase].
    Heynen U
    Z Allgemeinmed; 1970 Mar; 46(9):482-4. PubMed ID: 4256867
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of diarrhea with an eubiotic with enzyme activity (Mexase)].
    Nava M; Celestino S
    Prensa Med Mex; 1968; 33(1):57-8. PubMed ID: 4252872
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of nerobol and mexase in combination with mineral water from Morshin health resort in chronic colitis].
    Datsun TA
    Vrach Delo; 1976 Jun; (6):78-82. PubMed ID: 135416
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of Mexase in digestive pathology].
    Félix MH
    J Med Lyon; 1970 Mar; 51(182):663-78. PubMed ID: 4248934
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of the effect of mexaform in intestinal dyspepsia].
    Orlov VA; Gorbatenko VP; Ignatova NV; Rostsslavina OA; Dorogov IN
    Klin Med (Mosk); 1970 Oct; 48(10):90-2. PubMed ID: 4251427
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic effectiveness of mexaform, mexase and festal in chronic enterocolitis].
    Morozov KA; Valenkevich LN
    Vrach Delo; 1974 May; 5(0):97-100. PubMed ID: 4276279
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experience with a new enzyme preparation].
    José GS
    Schweiz Rundsch Med Prax; 1970 Sep; 59(37):1307-10. PubMed ID: 4253912
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of dyspepsia with a new poly-enzymatic drug].
    Dupérié MJ
    Bord Med; 1970 Apr; 3(4):1157-8 passim. PubMed ID: 5422403
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of Mexase].
    Florkiewicz H
    Pol Tyg Lek; 1970 Aug; 25(31):1178-9. PubMed ID: 4248516
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of acute exacerbations of the irritable colon].
    Kallai L
    Praxis; 1969 Sep; 58(39):1243-5. PubMed ID: 4242117
    [No Abstract]   [Full Text] [Related]  

  • 14. [Personal experience with the treatment of dyspeptic syndrome with a new drug combination].
    Di Vittorio G; Santelli G
    Clin Ter; 1978 Feb; 84(4):425-32. PubMed ID: 648099
    [No Abstract]   [Full Text] [Related]  

  • 15. [Outpatient treatment of intestinal diseases with Mexaform S].
    Friedrich R
    Landarzt; 1965 Feb; 41(5):210-2. PubMed ID: 4220846
    [No Abstract]   [Full Text] [Related]  

  • 16. [Digestive insufficiency and its treatment with a new three-phase enzyme drug].
    Krueger GA
    Landarzt; 1968 Aug; 44(24):1156-61. PubMed ID: 4236296
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with a new combination preparation--iodochlorhydroxyquin (Vioform)+4,7-phenantroline-5,6-quinone (Entobex) in the treatment of anti-infectious dyspepsia in infants and small children].
    Konzert W
    Wien Med Wochenschr; 1971 Nov; 121(45):808-11. PubMed ID: 4257622
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of dysbiotic intestinal disorders with Mexaform S].
    Dütsch L
    Med Welt; 1965 Jul; 29():1660-3. PubMed ID: 4220518
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of pansinorm-forté in gastric and intestinal dyspepsia].
    Orlov VA; Ryzhikov VN; Zelenchuk NM; Bakhtamova MM
    Sov Med; 1975 Oct; (10):83-5. PubMed ID: 1209335
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic action of 5-7-dechlore-8-hydroxyquinoline in intestinal diseases].
    Lebon J; Leutenegger M; Stora C; Illoul G
    Therapie; 1966; 21(5):1337-48. PubMed ID: 4227119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.